Genus (LON:GNS) Earns Buy Rating from Shore Capital

Genus (LON:GNS)‘s stock had its “buy” rating reissued by Shore Capital in a report issued on Thursday, Marketbeat Ratings reports. They currently have a GBX 2,900 target price on the stock. Shore Capital’s price target would indicate a potential upside of 8.01% from the stock’s current price.

Separately, Deutsche Bank Aktiengesellschaft increased their price objective on Genus from GBX 2,250 to GBX 2,550 and gave the company a “buy” rating in a research note on Tuesday, July 15th. Two equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company has an average rating of “Buy” and a consensus price target of GBX 2,725.

Genus Stock Down 2.7%

LON GNS opened at GBX 2,685 on Thursday. The business has a fifty day moving average price of GBX 2,451.67 and a 200 day moving average price of GBX 2,082.08. Genus has a one year low of GBX 1,424 and a one year high of GBX 3,228.80. The company has a debt-to-equity ratio of 53.12, a quick ratio of 1.08 and a current ratio of 1.80. The company has a market cap of £1.76 billion, a P/E ratio of -43,306.45, a P/E/G ratio of 2.87 and a beta of 0.37.

Genus (LON:GNS) last posted its quarterly earnings data on Thursday, September 4th. The company reported GBX 81.80 EPS for the quarter. Genus had a return on equity of 1.41% and a net margin of 1.18%. Research analysts anticipate that Genus will post 70.9644323 EPS for the current fiscal year.

About Genus

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.